Lymphatic thoracic duct ligation modulates the serum levels of IL-1β and IL-10 after intestinal ischemia/reperfusion in rats with the involvement of tumor necrosis factor α and nitric oxide

Shock

Volumn 27, Issue 2, 2007, Pages 209-213

  Cavriani, Gabriela ^a   Domingos, Helori Vanni ^a   Oliveira Filho, Ricardo Martins ^a   Sudo Hayashi, Lia Siguemi ^a   Vargaftig, Bernardo Boris ^a   De Lima, Wothan Tavares ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Lab de Fisiopatologia Da Inflamacão Experimental   (Brazil)

Author keywords

Cytokines; L NAME; Lymph; Mesenteric artery occlusion; Pentoxifylline; Systemic inflammation

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPERIMENTAL LIGATION; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INTESTINE ISCHEMIA; LYMPH ANALYSIS; LYMPHATIC SYSTEM; MALE; MESENTERIC ARTERY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; THORACIC DUCT;

ANIMALS; ENZYME INHIBITORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTESTINES; LIGATION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTOXIFYLLINE; RATS; RATS, WISTAR; REPERFUSION INJURY; THORACIC DUCT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846229577     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000238068.84826.52     Document Type: Article

References (29)

1. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple-organ failure syndrome. Arch Surg 121:196-208, 1986.
2. Harward TR, Brooks DL, Flynn TC, Seeger JM: Multiple organ dysfunction after mesenteric artery revascularization. J Vasc Surg 18:459-467, 1993.
3. Squadrito F, Altavilla D, Canale P, Ioculano M, Campo GM, Ammendolia L, Ferlito M, Zingarelli B, Squadrito G, Saitta A, et al.: Participation of tumor necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 113:1153-1158, 1994.
4. Koksoy C, Kuzu MA, Kuzu I, Ergun H, Gurhan I: Role of tumour necrosis factor in lung injury caused by intestinal ischaemia-reperfusion. Br J Surg 88:464-468, 2001.
5. Souza DG, Guabiraba R, Pinho V, Bristow A, Poole S, Teixeira MM: IL-1-driven endogenous IL-10 production protects against the systemic and local acute inflammatory response following intestinal reperfusion injury. J Immunol 170:4759-4766, 2005.
6. Yamamoto S, Tanabe M, Wakabayashi G, Shimazu M, Matsumoto K, Kitajima M: The role of tumor necrosis factor-α and interleukin-1β in ischemia-reperfusion injury of the rat small intestine. J Surg Res 99:134-141, 2001.
7. Feldmann M, Brennan FM, Foxwell BM, Maini RN: The role of TNFα and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 3:188-199, 2001.
8. Liu LM, Ward JA, Dubick MA: Hemorrhage-induced vascular hyporeactivity to norepinephrine in select vasculatures of rats and the roles of nitric oxide and endothelin. Shock 19:208-214, 2003.
9. Wang Y, Xu H, Mizoguchi K, Oe M, Maeta H: Intestinal ischemia induces late preconditioning against myocardial infarction: a role for inducible nitric oxide synthase. Cardiovasc Res 49:391-398, 2001.
10. Liu P, Xu B, Spokas E, Lai PS, Wong PY: Role of endogenous nitric oxide in TNF-alpha and IL-1beta generation in hepatic ischemia-reperfusion. Shock 13:217-223, 2000.
11. Liu P, Xu B, Hock CE: Inhibition of nitric oxide synthesis by L-name exacerbates acute lung injury induced by hepatic ischemia-reperfusion. Shock 16:211-217, 2001.
12. Cavriani G, Oliveira-Filho RM, Trezena AG, da Silva ZL, Domingos HV, de Arruda MJ, Jancar S, Tavares de Lima W: Lung microvascular permeability and neutrophil recruitment are differently regulated by nitric oxide in a rat model of intestinal ischemia-reperfusion. Eur J Pharmacol 494:241-249, 2004.
13. Deitch EA: Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 7:92-98, 2001.
14. Grotz MR, Ding J, Guo W, Huang Q, Deitch EA: Comparison of plasma cytokines levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 3:362-368, 1995.
15. Cavriani G, Domingos HV, Soares AL, Trezena AG, Ligeiro-Oliveira AP, Oliveira-Filho RM, Sudo-Hayashi LS, Tavares de Lima W: Lymphatic system as a path underlying the spread of lung and gut injury after intestinal ischemia/ reperfusion in rats. Shock 23:330-336, 2005.
16. Tilney NL: Patterns of lymphatic drainage in the adult laboratory rat. J Anat 109:369-383, 1971.
17. Sudo LS, Leme JG: The inflammatory responses of rats depleted of lymphocytes or with an artificial obstruction of the thoracic duct. Br J Exp Pathol 61:176-185, 1980.
18. Kotadia BK, Ravindranath TM, Choudhry MA, Haque F, Al Ghoul W, Sayeed MM: Effects of pentoxifylline on mesenteric lymph node T-cells in a rat model of thermal injury. Shock 20:517-520, 2003.
19. Davidson MT, Deitch EA, Lu Q, Osband A, Feketeova E, Nemeth ZH, Hasko G, Xu DZ: A study of the biologic activity of trauma-hemorrhagic shock mesenteric lymph over time and the relative role of cytokines. Surgery 136:32-41, 2004.
20. Narita K, Kuwabara Y, Fujii Y: Lung injury after intestinal ischemia-reperfusion may be avoided by the reduced absorption of locally produced cytokines. Surg Today 34:937-942, 2004.
21. Dominguez-Jimenez C, Sancho D, Nieto M, Montoya MC, Barreiro O, Sanchez-Madrid F, Gonzalez-Amaro R: Effect of pentoxifylline on polarization and migration of human leukocytes. J Leukoc Biol 71:588-596, 2002.
22. Van Leenen D, Van Der Poll T, Levi M, Ten Cate H, Van Deventer SJ, Hack CE, Aarden LA, Ten Cate JW: Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol 151:2318-2325, 1993.
23. Coimbra R, Loomis W, Melbostad H, Tobar M, Porcides RD, Hoyt DB: LPS-stimulated PMN activation and proinflammatory mediator synthesis is down-regulated by phosphodiesterase inhibition: role of pentoxifylline. J Trauma 57:1157-1163, 2004.
24. Ward DT, Lawson SA, Gallagher CM, Conner WC, Shea-Donohue T: Sustained nitric oxide production via L-arginine administration ameliorates effects of intestinal ischemia-reperfusion. J Surg Res 89:13-19, 2000.
25. Waisman D, Brod V, Dickstein R, Abramovich A, Rotschild A, Bitterman H: Effects of inhaled nitric oxide on lung injury after intestinal ischemia-reperfusion in rats. Shock 23:150-155, 2005.
26. Tavaf-Motamen H, Miner TJ, Starnes BW, Shea-Donohue T: Nitric oxide mediates acute lung injury by modulation of inflammation. J Surg Res 78:137-142, 1998.
27. Liu P, Xu B, Hock CE: Inhibition of nitric oxide synthesis by L-name exacerbates acute lung injury induced by hepatic ischemia-reperfusion. Shock 16:211-217, 2001.
28. Liu TH, Robinson EK, Helmer KS, West SD, Castaneda AA, Chang C, Mercer DW: Does upregulation of inducible nitric oxide synthase play a role in hepatic injury? Shock 18:549-554, 2002.
29. Lane JS, Todd KE, Lewis MP, Gloor B, Ashley SW, Reber HA, McFadden DW, Chandler CF: Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion. Surgery 122:288-294, 1997.